ABOUT US
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
VIDEOS
WEBINARS
BROCHURES AND DATASHEETS
- Advanced Automation System For Flexible Aseptic Filling
- Bioreactors Designed For Cell Growth And Expansion
- Antibody Production: Scale-Up Menu
- Allegro MVP Single-Use System
- An IoT Solution For A Reliable, Real-Time Informed Diagnosis
- A Flexible Service Model With Rapid Response And Access To Knowledge
- Online Service Solutions For Optimal Performance Of Your Instruments
- Single‑Use Filtration System For Pilot‑ And Small‑Scale Manufacturing
- A Ready-To-Use, Single-Use Liquid Chromatography System
- Mechanistic Chromatography Modeling To Accelerate Process Development
APPLICATION NOTES
- Balancing Protein A Resin Cost, Performance, And Productivity
- Optimizing TFF And SPTFF For High-Concentration mAb Formulations
- Selecting A Platform Filter For High Concentration mAbs
- Production Of A Highly Concentrated Monoclonal Antibody
- Extractables In Single-Use Systems Used In ADC Manufacturing
- Adapting Single-Use Chromatography To Manufacturing Scale
- Developing A Large-Scale Tangential Flow Filtration Process
- Bulk Filling Of Drug Substance | Accurate Aliquoting
- Sterilizing Grade Filter Performance With Biologic Drugs
- Developing A HIC Polishing Step For The Removal Of mAb Aggregates
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
![GettyImages-2095813668-meeting-sustainability-screen-learning]( "Biotech's Plastic Problem Meets Its Match")
Explore how a partnership with UW–Madison and Genentech developed a breakthrough recycling technology that is poised to reshape single-use bioprocessing sustainability.
-
![GettyImages-2185887801-sustainability-laptop-green-pencil]( "What Happens When You Refuse To Compromise On Sustainability?")
Discover how an empty building shell became a sustainable nanomedicine hub and achieved 47% energy savings and 88% fewer emissions, which sets new standards for innovation in the biologics industry.
-
![GettyImages-597972138-adeno-associated-virus-AAV]( "Facts About AAV Producer Cell Lines")
Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "3 Key Considerations In Gene Therapy Manufacturing")
Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
-
![Organs-body-organoid-study-GettyImages-1157550305]( "Ready To Demystify Organoids?")
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
![GettyImages-1382353763-hand-bubble-co2-green]( "Bio-Based Polymers Towards Net Zero In Single-Use Bioprocessing")
Decarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn why these energy-intensive sectors must act swiftly to reduce emissions and navigate complex global supply chains.
-
![GettyImages-2210692246-building-blocks-emissions-sustainability]( "Scope 3 Emissions: A Shared Challenge, A Collective Responsibility")
Despite growing sustainability efforts, our industry lags in climate goals, especially Scope 3 emissions. Discover why bold action and deep collaboration across the value chain are essential for real progress.
-
![GettyImages-2194013442-laboratory-scientists-computer-evaluating]( "5 Key Considerations For Companies Outsourcing Process Development")
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
![GettyImages-1284610189-laboratory-research-development-cell-culture]( "Face The Unknown: Key Bispecific Antibody Discoveries")
Bispecific antibodies (BsAbs) are revolutionizing biopharmaceuticals with enhanced therapeutic potential. Learn how advanced design tools and expert support streamline BsAb development from concept to clinic.
-
![injecting vaccine vaccination-GettyImages-665515600]( "21st Century Manufacturing Of Injectable Pharmaceuticals")
Discover how rising competition, niche patient populations, and evolving therapies are reshaping sterile injectable drug development with cutting-edge technologies.
